AstraZeneca PLC (AZN)
| Previous Close | 75.48 |
| Open | 75.69 |
| Bid | 75.65 x 200 |
| Ask | 75.75 x 400 |
| Day's Range | 75.34 - 75.75 |
| 52 Week Range | 60.47 - 76.58 |
| Volume | |
| Avg. Volume | 6,458,991 |
| Market Cap | 234.703B |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 37.48 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.45 (1.92%) |
| Ex-Dividend Date | Feb 22, 2024 |
| 1y Target Est | N/A |
- Reuters
FTSE 100 extends record streak on company news
(Reuters) -Britain's FTSE 100 extended its record rally for the fifth straight session on Monday, helped by positive corporate updates, while a stronger pound boosted midcaps. The mid-cap FTSE 250 advanced 1.3%, after touching highest levels in over thirteen months, and taking support from a rise in pound as the currency reached its highest in around two weeks against the dollar. FTSE 100 stocks move in an inverse relationship to the currency, earning their revenues in dollars while reporting profits in sterling, but they were supported by positive company news.
- Simply Wall St.
AstraZeneca PLC (LON:AZN) Beat Earnings, And Analysts Have Been Reviewing Their Forecasts
As you might know, AstraZeneca PLC ( LON:AZN ) just kicked off its latest quarterly results with some very strong...
- Zacks
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
